Artificial Intelligence(AI) in Healthcare Market – By Deployment, By Components , By Technology , By Operation Model , By Application , By Geography - Opportunity Analysis & Industry Forecast, 2024-2030.

Artificial Intelligence (AI) in Healthcare Market Overview

The Artificial Intelligence (AI) in Healthcare market size is forecast to reach US$333.7 billion by 2030, after growing at a CAGR of 48.0% during 2024-2030. AI in healthcare encompasses a wide range of technologies, including machine learning, natural language processing and robotics that are designed to enhance medical decision-making, improve patient outcomes, and optimize operational efficiency. From diagnostics to personalized medicine and administrative workflows, AI is revolutionizing how healthcare services are delivered and managed. Key drivers of this market include the rising demand for early disease detection, growing adoption of telemedicine and remote patient monitoring and advancements in AI-powered medical devices. Additionally, AI-enabled solutions help address critical challenges such as a shortage of healthcare professionals and increasing healthcare costs making them indispensable in modern medical practices.A major trend in the market is the integration of AI with wearable health technologies. Devices equipped with AI algorithms provide real-time health monitoring, predictive insights and data-driven recommendations to both patients and healthcare providers. For instance, in October 2023, a leading healthcare AI company introduced a wearable device capable of early detection of cardiac arrhythmias enabling timely intervention. Another trend is the use of AI in drug discovery and development. AI significantly reduces the time and cost of bringing new drugs to market by analyzing vast datasets identifying potential drug candidates, and optimizing clinical trials. Companies like DeepMind and Insilico Medicine are leveraging AI to revolutionize the pharmaceutical landscape.

Artificial Intelligence(AI) in Healthcare Market - Report Coverage:

The “Artificial Intelligence (AI) in Healthcare Market Report - Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Artificial Intelligence in Healthcare Market.

COVID-19 / Ukraine Crisis - Impact Analysis:  

• The pandemic accelerated the adoption of Artificial Intelligence in Healthcare as the demand for advanced diagnostic tools, remote monitoring solutions, and virtual healthcare services surged. AI-powered technologies played a pivotal role in early COVID-19 detection, vaccine development and predicting virus spread patterns. However, disruptions in supply chains and reduced hospital revenues during the pandemic temporarily hindered the deployment of AI systems.
• The Russia-Ukraine war led to increased geopolitical instability indirectly impacting healthcare investments and funding in affected regions. However, the crisis underscored the importance of AI in addressing healthcare challenges, such as providing remote healthcare solutions in conflict zones and analyzing medical data for crisis management. The need for resilient, scalable AI-powered healthcare systems became evident during such emergencies, driving further innovation in the sector.

Key Takeaways

Diagnostics and Decision Support is the Largest Segment

AI-powered diagnostic tools and decision support systems are revolutionizing healthcare by enabling the early detection of diseases and supporting clinical decisions. These systems leverage advanced algorithms to analyze medical images, genetic data and patient records with high accuracy. For instance, AI-based imaging tools have demonstrated sensitivity rates exceeding 90% in detecting cancers like breast and lung. By minimizing diagnostic errors and enhancing precision, these tools reduce healthcare costs and improve patient outcomes. According to a study published in the Journal of the American Medical Association, an AI system properly recognized breast cancer in mammograms with a sensitivity of 94.5%. The global AI healthcare diagnostic market is projected to grow significantly, driven by increased adoption of AI in pathology and radiology departments worldwide.

On Premise is the Largest Segment

Healthcare organizations often deal with sensitive patient data, and on-premise solutions provide greater control over data security. This is particularly important for organizations in highly regulated industries like healthcare. On-premise solutions can be more easily tailored to comply with specific regulatory requirements, such as HIPAA in the US and GDPR in the EU. While cloud-based solutions are gaining popularity, on-premise deployments continue to be a preferred choice for many healthcare organizations, especially those with stringent data security and privacy requirements. In March 2024, OVES Enterprise, a software development company and drone manufacturer, launched Storm Shadow AI, an advanced artificial intelligence solution that can learn in record time to make quick and precise decisions in critical scenarios. Besides military applications, the solution can also be used in critical locations such as hospitals. 

North America Dominates the Market

North America holds the largest share of the AI in healthcare market, accounting for over 40% of market share in 2023. The region's dominance is driven by robust healthcare infrastructure, favorable government policies, and investments in AI research. According to the U.S. FDA, over 500 AI and machine learning-enabled medical devices were approved by 2022, illustrating the region’s leadership in innovation. Initiatives like Canada’s Pan-Canadian AI Strategy also support AI-driven healthcare projects. North America’s focus on enhancing personalized medicine and deploying AI for chronic disease management further consolidates its position as a global leader in this domain.

Rising Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases like diabetes, cancer, and cardiovascular disorders has heightened the need for AI in healthcare. According to the World Health Organization, chronic diseases account for 70% of deaths globally, necessitating innovative solutions for early detection and personalized care. AI systems excel at identifying patterns in vast datasets, helping predict disease onset and progression. For example, IBM Watson Health’s AI platform aids oncologists by analyzing clinical data and offering tailored treatment options. The global market for AI in chronic disease management is anticipated to grow at a CAGR of 40% during the next decade.

Data Privacy and Security Concerns to Hamper the Market

Data privacy and security remain significant barriers to the widespread adoption of AI in healthcare. The sensitive nature of patient health records makes them a prime target for cyberattacks. In 2023 alone, healthcare data breaches affected over 50 million records, according to the U.S. Department of Health and Human Services. Regulatory frameworks like HIPAA and GDPR impose stringent requirements on how patient data is collected, stored, and processed, complicating AI implementation. Ensuring compliance while leveraging AI technologies poses a challenge for healthcare providers, necessitating robust cybersecurity measures and transparent data-sharing practices.

For more details on this report - Request for Sample

Key Market Players

Global Sports Protective Equipment top 10 companies include:

1. Google Inc.
2. IBM
3. Butterfly Network
4. GE Healthcare
5. Tempus
6. CloudMedX
7. Cleerly
8. Caption Health
9. Medtronic plc
10. Enlitic

Scope of the Report:

For more Information and Communications Technology Market reports, please click here